Nayyef Aljaar, Mohammad A. Qaderi, Iman A. Mansi, Majed Shtaiwi, Akef Alhmaideen, Mahmoud Al-Refaib, Mousa Al-Noaimi, Bashaer Abu-Irmaileh, Kamal Kant, Chandi C. Malakar
{"title":"铜催化C─N和C─S键合成1H, 6h -苯并[d]嘧啶[2,1-b][1,3]噻嗪-1- 1的方法:对癌细胞的细胞毒活性评价","authors":"Nayyef Aljaar, Mohammad A. Qaderi, Iman A. Mansi, Majed Shtaiwi, Akef Alhmaideen, Mahmoud Al-Refaib, Mousa Al-Noaimi, Bashaer Abu-Irmaileh, Kamal Kant, Chandi C. Malakar","doi":"10.1002/slct.202502223","DOIUrl":null,"url":null,"abstract":"<p>A copper(I)-catalyzed regioselective strategy has been put forth toward the effective synthesis of 1<i>H</i>,6<i>H</i>-benzo[<i>d</i>]pyrimido[2,1-<i>b</i>][1,3]thiazin-1-ones <b>4</b> via the cascade intermolecular <i>S</i>-benzylation and intramolecular <i>N</i>-arylation processes. The developed method has been accomplished by the reaction between 2-iodobenzyl bromides <b>1</b> and 2-thioxo-2,3-dihydropyrimidin-4(1<i>H</i>)-ones as the easily available substrates under the influence of Cu(I)-catalyst to afford the corresponding product <b>4</b> in yields up to 89%. The resulting <i>N</i>-heterocyclic moieties were examined for cytotoxic activities against cancer cell lines. It was investigated that the molecule <b>4a</b> was effective against Leukemia (K562) cell lines with acceptable IC<sub>50</sub> value of 10.0 ± 2.9 µM; molecules <b>4d</b>, <b>4j</b>, <b>4q</b>, and <b>4r</b> were moderately active against MCF-7 breast cancer cell lines and compounds <b>4a</b>, <b>4d</b>, <b>4n</b>, <b>4q</b>, and <b>4r</b> were also found to exhibit moderate activities against MDA-MB-231 breast cancer cell lines. Further modifications of these bioactive molecules may lead to effective anticancer drug candidates.</p>","PeriodicalId":146,"journal":{"name":"ChemistrySelect","volume":"10 26","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Copper-Catalyzed C─N and C─S Bonds Formation Approach Toward the Synthesis of 1H,6H-Benzo[d]pyrimido[2,1-b][1,3]thiazin-1-ones: Evaluation of Their Cytotoxic Activities Against Cancer Cell Lines\",\"authors\":\"Nayyef Aljaar, Mohammad A. Qaderi, Iman A. Mansi, Majed Shtaiwi, Akef Alhmaideen, Mahmoud Al-Refaib, Mousa Al-Noaimi, Bashaer Abu-Irmaileh, Kamal Kant, Chandi C. Malakar\",\"doi\":\"10.1002/slct.202502223\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A copper(I)-catalyzed regioselective strategy has been put forth toward the effective synthesis of 1<i>H</i>,6<i>H</i>-benzo[<i>d</i>]pyrimido[2,1-<i>b</i>][1,3]thiazin-1-ones <b>4</b> via the cascade intermolecular <i>S</i>-benzylation and intramolecular <i>N</i>-arylation processes. The developed method has been accomplished by the reaction between 2-iodobenzyl bromides <b>1</b> and 2-thioxo-2,3-dihydropyrimidin-4(1<i>H</i>)-ones as the easily available substrates under the influence of Cu(I)-catalyst to afford the corresponding product <b>4</b> in yields up to 89%. The resulting <i>N</i>-heterocyclic moieties were examined for cytotoxic activities against cancer cell lines. It was investigated that the molecule <b>4a</b> was effective against Leukemia (K562) cell lines with acceptable IC<sub>50</sub> value of 10.0 ± 2.9 µM; molecules <b>4d</b>, <b>4j</b>, <b>4q</b>, and <b>4r</b> were moderately active against MCF-7 breast cancer cell lines and compounds <b>4a</b>, <b>4d</b>, <b>4n</b>, <b>4q</b>, and <b>4r</b> were also found to exhibit moderate activities against MDA-MB-231 breast cancer cell lines. Further modifications of these bioactive molecules may lead to effective anticancer drug candidates.</p>\",\"PeriodicalId\":146,\"journal\":{\"name\":\"ChemistrySelect\",\"volume\":\"10 26\",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-07-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ChemistrySelect\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/slct.202502223\",\"RegionNum\":4,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemistrySelect","FirstCategoryId":"92","ListUrlMain":"https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/slct.202502223","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Copper-Catalyzed C─N and C─S Bonds Formation Approach Toward the Synthesis of 1H,6H-Benzo[d]pyrimido[2,1-b][1,3]thiazin-1-ones: Evaluation of Their Cytotoxic Activities Against Cancer Cell Lines
A copper(I)-catalyzed regioselective strategy has been put forth toward the effective synthesis of 1H,6H-benzo[d]pyrimido[2,1-b][1,3]thiazin-1-ones 4 via the cascade intermolecular S-benzylation and intramolecular N-arylation processes. The developed method has been accomplished by the reaction between 2-iodobenzyl bromides 1 and 2-thioxo-2,3-dihydropyrimidin-4(1H)-ones as the easily available substrates under the influence of Cu(I)-catalyst to afford the corresponding product 4 in yields up to 89%. The resulting N-heterocyclic moieties were examined for cytotoxic activities against cancer cell lines. It was investigated that the molecule 4a was effective against Leukemia (K562) cell lines with acceptable IC50 value of 10.0 ± 2.9 µM; molecules 4d, 4j, 4q, and 4r were moderately active against MCF-7 breast cancer cell lines and compounds 4a, 4d, 4n, 4q, and 4r were also found to exhibit moderate activities against MDA-MB-231 breast cancer cell lines. Further modifications of these bioactive molecules may lead to effective anticancer drug candidates.
期刊介绍:
ChemistrySelect is the latest journal from ChemPubSoc Europe and Wiley-VCH. It offers researchers a quality society-owned journal in which to publish their work in all areas of chemistry. Manuscripts are evaluated by active researchers to ensure they add meaningfully to the scientific literature, and those accepted are processed quickly to ensure rapid online publication.